BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Mehta A, Tong Z, Esser L, Voelcker NH. Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges. Adv Sci (Weinh) 2021;8:2003937. [PMID: 34026447 DOI: 10.1002/advs.202003937] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee CY, Chooi WH, Ng S, Chew SY. Modulating neuroinflammation through molecular, cellular and biomaterial‐based approaches to treat spinal cord injury. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10389] [Reference Citation Analysis]
2 Carton F, Malatesta M. In Vitro Models of Biological Barriers for Nanomedical Research. IJMS 2022;23:8910. [DOI: 10.3390/ijms23168910] [Reference Citation Analysis]
3 Li C, Qin S, Wen Y, Zhao W, Huang Y, Liu J. Overcoming the blood-brain barrier: Exosomes as theranostic nanocarriers for precision neuroimaging. J Control Release 2022;349:902-16. [PMID: 35932883 DOI: 10.1016/j.jconrel.2022.08.002] [Reference Citation Analysis]
4 La Barbera L, Mauri E, D’amelio M, Gori M. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives. Front Neurosci 2022;16:939855. [DOI: 10.3389/fnins.2022.939855] [Reference Citation Analysis]
5 Smith BC, Tinkey RA, Shaw BC, Williams JL. Targetability of the neurovascular unit in inflammatory diseases of the central nervous system. Immunol Rev 2022. [PMID: 35909222 DOI: 10.1111/imr.13121] [Reference Citation Analysis]
6 Caraway CA, Gaitsch H, Wicks EE, Kalluri A, Kunadi N, Tyler BM. Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches. Polymers 2022;14:2963. [DOI: 10.3390/polym14142963] [Reference Citation Analysis]
7 Luo M, Lee LKC, Peng B, Choi CHJ, Tong WY, Voelcker NH. Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases. Advanced Science. [DOI: 10.1002/advs.202201740] [Reference Citation Analysis]
8 Ramakrishnan S, Li H, Xu Y, Shin D, Dursun I, Cotlet M, Zhang Y, Yu Q. Ruddlesden–Popper Perovskites with Narrow Phase Distribution for Air‐Stable Solar Cells. Solar RRL. [DOI: 10.1002/solr.202200490] [Reference Citation Analysis]
9 Wamhoff EC, Romanov A, Huang H, Read BJ, Ginsburg E, Knappe GA, Kim HM, Farrell NP, Irvine DJ, Bathe M. Controlling Nuclease Degradation of Wireframe DNA Origami with Minor Groove Binders. ACS Nano 2022. [PMID: 35640255 DOI: 10.1021/acsnano.1c11575] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mir M, Palma-Florez S, Lagunas A, López-Martínez MJ, Samitier J. Biosensors Integration in Blood-Brain Barrier-on-a-Chip: Emerging Platform for Monitoring Neurodegenerative Diseases. ACS Sens 2022;7:1237-47. [PMID: 35559649 DOI: 10.1021/acssensors.2c00333] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Naki T, Aderibigbe BA. Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer. Pharmaceutics 2022;14:1048. [DOI: 10.3390/pharmaceutics14051048] [Reference Citation Analysis]
12 Ramburrun P, Khan RA, Choonara YE. Design, preparation, and functionalization of nanobiomaterials for enhanced efficacy in current and future biomedical applications. Nanotechnology Reviews 2022;11:1802-26. [DOI: 10.1515/ntrev-2022-0106] [Reference Citation Analysis]
13 Liu Y, Yang G, Hui Y, Ranaweera S, Zhao CX. Microfluidic Nanoparticles for Drug Delivery. Small 2022;:e2106580. [PMID: 35396770 DOI: 10.1002/smll.202106580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tehrani SF, Rabanel J, Legeay S, Cayon J, Riou J, Saulnier P, Marleau S, Gaëlle Roullin V, Hildgen P, Bastiat G. Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.04.003] [Reference Citation Analysis]
15 Bendre A, Bhat MP, Lee K, Altalhi T, Alruqi MA, Kurkuri M. Recent developments in microfluidic technology for synthesis and toxicity-efficiency studies of biomedical nanomaterials. Materials Today Advances 2022;13:100205. [DOI: 10.1016/j.mtadv.2022.100205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
16 Annu, Sartaj A, Qamar Z, Md S, Alhakamy NA, Baboota S, Ali J. An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor. Front Bioeng Biotechnol 2022;10:788128. [DOI: 10.3389/fbioe.2022.788128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang L, Li Y, Ren M, Wang X, Li L, Liu F, Lan Y, Yang S, Song J. pH and lipase-responsive nanocarrier-mediated dual drug delivery system to treat periodontitis in diabetic rats. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.02.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wijaya A, Wang Y, Tang D, Zhong Y, Liu B, Yan M, Jiu Q, Wu W, Wang G. A study of lovastatin and L-arginine co-loaded PLGA nanomedicine for enhancing nitric oxide production and eNOS expression. J Mater Chem B 2022;10:607-24. [PMID: 34994373 DOI: 10.1039/d1tb01455b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Drug release study of the chitosan-based nanoparticles. Heliyon 2022;8:e08674. [PMID: 35028457 DOI: 10.1016/j.heliyon.2021.e08674] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
20 Bonilla L, Esteruelas G, Ettcheto M, Espina M, García ML, Camins A, Souto EB, Cano A, Sánchez-López E. Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges. Epilepsia Open 2021. [PMID: 34862851 DOI: 10.1002/epi4.12567] [Reference Citation Analysis]
21 Ribovski L, Hamelmann NM, Paulusse JMJ. Polymeric Nanoparticles Properties and Brain Delivery. Pharmaceutics 2021;13:2045. [PMID: 34959326 DOI: 10.3390/pharmaceutics13122045] [Reference Citation Analysis]
22 Rabha B, Bharadwaj KK, Pati S, Choudhury BK, Sarkar T, Kari ZA, Edinur HA, Baishya D, Atanase LI. Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update. Polymers (Basel) 2021;13:4114. [PMID: 34883617 DOI: 10.3390/polym13234114] [Reference Citation Analysis]
23 Ravichandran V, Lee M, Nguyen Cao TG, Shim MS. Polysorbate-Based Drug Formulations for Brain-Targeted Drug Delivery and Anticancer Therapy. Applied Sciences 2021;11:9336. [DOI: 10.3390/app11199336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
24 Zheng M, Du Q, Wang X, Zhou Y, Li J, Xia X, Lu Y, Yin J, Zou Y, Park JB, Shi B. Tuning the Elasticity of Polymersomes for Brain Tumor Targeting. Adv Sci (Weinh) 2021;8:e2102001. [PMID: 34423581 DOI: 10.1002/advs.202102001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Nair AL, Mesch L, Schulz I, Becker H, Raible J, Kiessling H, Werner S, Rothbauer U, Schmees C, Busche M, Trennheuser S, Fricker G, Stelzle M. Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to Study the Interaction of 3D Tumor Spheroids with Cellular Barriers. Biosensors (Basel) 2021;11:314. [PMID: 34562904 DOI: 10.3390/bios11090314] [Reference Citation Analysis]
26 Pensado-López A, Fernández-Rey J, Reimunde P, Crecente-Campo J, Sánchez L, Torres Andón F. Zebrafish Models for the Safety and Therapeutic Testing of Nanoparticles with a Focus on Macrophages. Nanomaterials (Basel) 2021;11:1784. [PMID: 34361170 DOI: 10.3390/nano11071784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]